3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
7
NIH
7
NETWORK
6
INDUSTRY
4
INDIV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Retroperitoneal liposarcoma
1
Liposarcoma
1
Leiomyosarcoma
1
Chondrosarcoma
1
Interventions
nilotinib
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDIV
×
Liposarcoma
×
Doxorubicin
×
Clear all
NCT02587169
2015-10-27
GEIS-27
Broto, Javier MartÃn, M.D.
Phase 1/2
Unknown
40 enrolled